Ausbil Investment Management Ltd acquired a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 5,081 shares of the real estate investment trust's stock, valued at approximately $356,000.
Other institutional investors have also added to or reduced their stakes in the company. MetLife Investment Management LLC grew its holdings in National Health Investors by 706.6% during the 1st quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust's stock worth $15,786,000 after acquiring an additional 187,233 shares during the last quarter. Bowen Hanes & Co. Inc. bought a new stake in shares of National Health Investors in the 1st quarter valued at $10,340,000. Nuveen LLC bought a new stake in shares of National Health Investors in the 1st quarter valued at $10,126,000. Centersquare Investment Management LLC boosted its stake in shares of National Health Investors by 25.7% in the 1st quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust's stock valued at $36,632,000 after purchasing an additional 101,538 shares during the last quarter. Finally, Jane Street Group LLC boosted its stake in shares of National Health Investors by 1,728.4% in the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock valued at $5,148,000 after purchasing an additional 65,885 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have recently commented on NHI. Wells Fargo & Company upped their price objective on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 27th. Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. Truist Financial upped their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Finally, KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price on the stock in a research note on Thursday, July 10th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, National Health Investors has a consensus rating of "Buy" and an average target price of $82.25.
Check Out Our Latest Report on National Health Investors
National Health Investors Price Performance
Shares of NYSE:NHI opened at $79.70 on Friday. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $3.78 billion, a PE ratio of 25.46, a P/E/G ratio of 3.43 and a beta of 0.76. National Health Investors, Inc. has a twelve month low of $65.13 and a twelve month high of $84.16. The company has a 50-day moving average price of $75.81 and a two-hundred day moving average price of $73.94.
National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company had revenue of $70.27 million during the quarter, compared to analyst estimates of $86.46 million. During the same period last year, the business earned $1.18 earnings per share. National Health Investors's revenue was up 6.7% compared to the same quarter last year. Equities analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current year.
National Health Investors Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Tuesday, September 30th. This is a boost from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 annualized dividend and a yield of 4.6%. National Health Investors's dividend payout ratio (DPR) is presently 117.57%.
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.